Nathan Steven D
Lung Transplant Program, INOVA Heart and Lung Transplant Center, INOVA Fairfax Hospital, Falls Church, VA 22042, USA.
Chest. 2005 Mar;127(3):1006-16. doi: 10.1378/chest.127.3.1006.
The timing of the referral and listing of patients for lung transplantation remains a difficult decision. Life expectancy and quality of life with and without transplantation are the pivotal issues that need to be considered by physicians and presented to prospective transplant candidates. The recognition of recent advances in the understanding of the various primary diseases, other potential therapies, and the latest posttransplant statistics are essential for a balanced discussion or decision about lung transplantation. This article provides a review of these and other pertinent issues for patients with various forms of advanced lung disease.
为患者安排肺移植转诊和列入名单的时机仍然是一个艰难的决定。移植或不移植情况下的预期寿命和生活质量是医生需要考虑并告知潜在移植候选人的关键问题。了解各种原发性疾病的最新进展、其他潜在治疗方法以及最新的移植后统计数据，对于就肺移植进行全面的讨论或决策至关重要。本文对患有各种晚期肺部疾病患者的这些及其他相关问题进行了综述。
